Marwan Fakih, M.D. / Professor

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    AstraZeneca
    Date added: 
    07/12/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Bayer
    Date added: 
    07/12/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Bristol Myers Squibb
    Date added: 
    07/12/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Incyte Corporation
    Date added: 
    07/12/2023
    Relationship end date: 
    01/20/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Mirati Therapeutics
    Date added: 
    07/12/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Nouscom
    Date added: 
    07/12/2023
    Relationship end date: 
    05/04/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Roche/Genentech
    Date added: 
    07/12/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Taiho Oncology
    Date added: 
    07/12/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    AgenusBio
    Date added: 
    07/12/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Genentech
    Date added: 
    07/12/2023
Return to 2023 San Diego Hematology Oncology Conference